CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists

被引:0
|
作者
Elena Cichero
Sara Cesarini
Luisa Mosti
Paola Fossa
机构
[1] Università degli Studi di Genova,Dipartimento di Scienze Farmaceutiche
来源
关键词
Cannabinoid receptor; CB2 agonist; CoMFA; CoMSIA; 3D-QSAR;
D O I
暂无
中图分类号
学科分类号
摘要
Novel classes of CB2 agonists based on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine scaffolds have shown high binding affinity toward CB2 receptor and good selectivity over CB1. A computational study of comparative molecular fields analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) was performed, in order to identify the key structural features impacting their binding affinity. The final CoMSIA model resulted to be the more predictive, showing \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ r_{ncv}^2 = 0.84 $$\end{document}, \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ r_{cv}^2 = ~0.619 $$\end{document}, SEE = 0.369, and \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ r_{pred}^2 = 0.75 $$\end{document}. The study provides useful suggestions for the synthesis of new selective analogues with improved affinity.
引用
收藏
页码:677 / 691
页数:14
相关论文
共 50 条
  • [41] Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2
    Tsuzuki, Y
    Tomita, K
    Shibamori, K
    Sato, Y
    Kashimoto, S
    Chiba, K
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (08) : 2097 - 2109
  • [42] (2,6-Bis{5-amino-3-tert-butyl-4-[(3-methyl-1,2,4-thiadiazol-5-yl)diazenyl]-1H-pyrazol-1-yl}-4-oxo-1,4-dihydro-1,3,5-triazin-1-ido)methanol(phenol)sodium phenol tetrasolvate
    Shibata, Hiroki
    Mizuguchi, Jin
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : M463 - U1180
  • [43] PYRIDONECARBOXYLIC ACIDS AS ANTIBACTERIAL AGENTS .2. SYNTHESIS AND STRUCTURE ACTIVITY RELATIONSHIPS OF 1,6,7-TRISUBSTITUTED 1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACIDS, INCLUDING ENOXACIN, A NEW ANTIBACTERIAL AGENT
    MATSUMOTO, J
    MIYAMOTO, T
    MINAMIDA, A
    NISHIMURA, Y
    EGAWA, H
    NISHIMURA, H
    JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (03) : 292 - 301
  • [44] ASYMMETRIC-SYNTHESIS AND PROPERTIES OF THE ENANTIOMERS OF THE ANTIBACTERIAL AGENT 7-(3-AMINOPYRROLIDIN-1-YL)-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-6-FLUORO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
    ROSEN, T
    CHU, DTW
    LICO, IM
    FERNANDES, PB
    SHEN, L
    BORODKIN, S
    PERNET, AG
    JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (08) : 1586 - 1590
  • [45] Metabolism of (+)-1,4-Dihydro-7-(trans-3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic Acid (Voreloxin; Formerly SNS-595), a Novel Replication-Dependent DNA-Damaging Agent
    Evanchik, Marc J.
    Allen, Darin
    Yoburn, Josh C.
    Silverman, Jeffrey A.
    Hoch, Ute
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (03) : 594 - 601
  • [46] Crystal structure of catena-poly[(μ2-benzene-1,4-dicarboxylato-κ2O:O′) (1-ethyl-6-fluoro-7-(4-methylpiperazin-1-ium-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylato-κ2O,O′) zinc(II)] 1.25 hydrate, C25H26.5N3O8.25FZn
    Hu, Yong-Jun
    Jin, Lie
    Zhu, Ling
    Zhou, Tian
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2017, 232 (06): : 923 - 925
  • [47] Synthesis and Biological Evaluation of N′-(2-Hydroxybenzylidene)-1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carbohydrazide and Its Complexes with Cu(II), Ni(II), Zn(II) and Fe(III)
    Deeba, Farah
    Khan, Muhammad Naeem
    Abbas, Naeem
    Khan, Misbahul Ain
    Khan, Rauf Ahmad
    ASIAN JOURNAL OF CHEMISTRY, 2013, 25 (15) : 8351 - 8354
  • [48] 7-[(7S)-7-Azaniumyl-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1S,2R)-2-fluorocyclopropyl]-4-oxo-1,4-dihydro-quinoline-3-carboxylate methanol monosolvate
    Xu, Wen-jie
    Qiu, Xue-hui
    Hua, Huai-jie
    Tan, Song-de
    Ding, Hai-yan
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O2794 - +
  • [49] Crystal structure of poly-(bis(1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylato)nickel (II)) dihydrate, Ni(C15H15FN4O3)2 • 2H2O
    Sun, Xue-Bin
    Wu, Yan-Li
    Lin, Feng
    An, Zhe
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2007, 222 (01): : 75 - 76
  • [50] SYNTHESIS OF [H-3] TERT-BUTYL 8-CHLORO-5,6-DIHYDRO-5-METHYL-6-OXO-4H-IMIDAZO[1,5-A][1,4]BENZODIAZEPINE 3-CARBOXYLATE, A SELECTIVE, HIGH-AFFINITY LIGAND FOR THE DIAZEPAM INSENSITIVE (DI) SUBTYPE OF THE BENZODIAZEPINE RECEPTOR
    GU, ZQ
    DECOSTA, BR
    WONG, G
    RICE, KC
    SKOLNICK, P
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1992, 31 (12): : 1049 - 1055